Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Navidea Biopharmaceuticals Inc (NAVB)

2.62   0 (0%) 06-01 11:10
Open: 2.51 Pre. Close: 2.62
High: 2.65 Low: 2.5
Volume: 252,475 Market Cap: 57M
Navidea Biopharmaceuticals Inc is a biotechnology company engaged in precision medicine. Its products are designed to assist in the identification of undetected diseases and develop treatment for cancer, autoimmune conditions, and inflammatory diseases.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.633 - 2.643 2.643 - 2.651
Low: 2.425 - 2.437 2.437 - 2.446
Close: 2.601 - 2.621 2.621 - 2.636

Technical analysis

as of: 2020-06-01 11:00:53 AM
Overall:       
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 4.09     One year: 4.77
Support: Support1: 1.77    Support2: 0.70
Resistance: Resistance1: 3.50    Resistance2: 4.09
Pivot: 1.69
Moving Average: MA(5): 2.55     MA(20): 1.49
MA(100): 1.10     MA(250): 0.90
MACD: MACD(12,26): 0.46     Signal(9): 0.31
Stochastic oscillator: %K(14,3): 66.14     %D(3): 64.10
RSI: RSI(14): 85.70
52-week: High: 3.50  Low: 0.49  Change(%): 94.7
Average Vol(K): 3-Month: 167940  10-Days: 949270

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
NAVB has closed below upper band by 16.7%. Bollinger Bands are 530.3% wider than normal. The large width of the bands suggest high volatility as compared to NAVB's normal range. The bands have been in this wide range for 8 bars. This is a sign that the current trend might continue.

Headline News

Thu, 21 May 2020
Navidea Biopharmaceuticals Announces Positive Results of Second Interim Analysis of Ongoing Phase 2B Study in Rheumatoid Arthritis - Business Wire

Fri, 22 May 2020
NAVB Stock Price: Navidea Biopharmaceuticals doubles in value, not coronavirus related - FXStreet

Thu, 14 May 2020
Navidea Biopharmaceuticals Reports First Quarter 2020 Financial Results - Business Wire

Mon, 11 May 2020
Navidea Biopharmaceuticals Regains Commercialization and Distributions Rights in Europe for LYMPHOSEEK® - Business Wire

Thu, 07 May 2020
Navidea Biopharmaceuticals to Host First Quarter 2020 Earnings Conference Call and Corporate Update - Yahoo Finance

Fri, 29 May 2020
Is Navidea Biopharmaceuticals Inc (NAVB) Stock a Smart Investment? - InvestorsObserver

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  AMEX
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 22
Shares Float (M) 14
% Held by Insiders 49.21
% Held by Institutions 3.57
Shares Short (K) 532
Shares Short P. Month (K) 536

Stock Financials

EPS -0.661
EPS Est This Year -0.080
EPS Est Next Year -0.030
Book Value (p.s.) -0.090
Profit Margin
Operating Margin -1449.92
Return on Assets (ttm) -148.4
Return on Equity (ttm)
Qtrly Rev. Growth 275.4
Gross Profit (p.s.) 0.030
Sales Per Share 0.036
EBITDA (p.s.) -0.512
Qtrly Earnings Growth
Operating Cash Flow (M) -8
Levered Free Cash Flow (M) -7

Stock Valuations

PE Ratio -3.98
PEG Ratio
Price to Book value -29.20
Price to Sales 73.66
Price to Cash Flow -6.99

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.